N- [4-[(7-Chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl) carbonyl] -3-methylphenyl] -2-methylbenzamide CAS 137973-76 -3

Khoom Piav Qhia:

Khoom Lub Npe:

N- [4-[(7-Chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl) carbonyl] -3-methylphenyl] -2-methylbenzamide CAS TSIS TAU: 137973 -76-3

Lub ntsiab lus:

7-chloro-1- [2-methyl-4-[(2-methylbenzoyl) amino] benzoyl] -5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine;

5-oxo-7-chloro-1- [2-methyl-4- (2-methylbenzoylamino) benzoyl] -2,3,4,5-tetra-hydro-1H-benzoazepine;

7-chloro-1- [2-methyl-4- (2-methylbenzoylamino) -benzoyl] -2,3,4,5-tetrahydro-1H-1-benzazepin-5-ib;

Tshuaj& Lub Cev Muaj Zog:

Tshwm sim: Khoom

Kev Ntsuas: ≥99.00%

Ceev: 1.307

Kub Point: 593.224 ℃ ntawm 760 mmHg

Flash Point: 312.571 ℃

Vapor Siab: 0.0 ± 1.7 mmHg ntawm 25 ℃

Index ntawm Refraction: 1.655

Cov Ntaub Ntawv Kev Nyab Xeeb:

HS Code: 2933990090

5-Dehydro Tolvaptan yog qhov tsis huv ntawm Tolvaptan, xaiv, sib tw arginine vasopressin V2 receptor antagonist siv los kho hyponatremia (qib ntshav sodium tsawg) cuam tshuam nrog lub plawv tsis ua haujlwm, mob ntshav qab zib, thiab cov tsos mob ntawm kev tsis tsim nyog antidiuretic hormone (SIADH).

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: n- [4-[(7-chloro-2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl) carbonyl] -3-methylphenyl] -2-methylbenzamide cas 137973-76 -3, cov chaw tsim khoom, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

• Tug: 2-methyl-4- (2-methyl-benzoylamino) -benzoic Acid CAS 317374-08-6
• Tom ntej: 1- (4-Amino-2-methylbenzoyl) -7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ib CAS 137977-97-0